CMIC HOLDINGS Co (TSE:2309) EBIT per Share : 円527.47 (TTM As of Dec. 2023)

View and export this data going back to 2002. Start your Free Trial

What is CMIC HOLDINGS Co EBIT per Share?

CMIC HOLDINGS Co's EBIT per Share for the three months ended in Dec. 2023 was 円30.09. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 was 円527.47.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for CMIC HOLDINGS Co's EBIT per Share or its related term are showing as below:

TSE:2309's 3-Year EBIT Growth Rate is not ranked ^*
in the Medical Diagnostics & Research industry.
Industry Median: -1.7
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

CMIC HOLDINGS Co's EBIT for the three months ended in Dec. 2023 was 円508 Mil.

CMIC HOLDINGS Co EBIT per Share Historical Data

The historical data trend for CMIC HOLDINGS Co's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CMIC HOLDINGS Co EBIT per Share Chart

CMIC HOLDINGS Co Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

EBIT per Share

Get a 7-Day Free Trial

196.99

114.93

199.39

694.41

712.41

CMIC HOLDINGS Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EBIT per Share	Get a 7-Day Free Trial															195.74	439.06	130.39	-72.08	30.09

CMIC HOLDINGS Co EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

CMIC HOLDINGS Co's EBIT per Share for the fiscal year that ended in Sep. 2023 is calculated as

	EBIT per Share		(A: Sep. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	12029	/	16.885
=	712.41

CMIC HOLDINGS Co's EBIT per Share for the quarter that ended in Dec. 2023 is calculated as

	EBIT per Share		(Q: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	508	/	16.885
=	30.09

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円527.47

CMIC HOLDINGS Co (TSE:2309) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

CMIC HOLDINGS Co EBIT per Share Related Terms

Thank you for viewing the detailed overview of CMIC HOLDINGS Co's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

CMIC HOLDINGS Co (TSE:2309) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » CMIC HOLDINGS Co Ltd (TSE:2309) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

Hamamatsucho Building, 1-1-1 Shibaura, Minato-ku, Tokyo, JPN, 105-0023

Website

https://www.cmicgroup.com

CMIC HOLDINGS Co Ltd is a Japan-based management consulting company. It contributes to the development of the medical and healthcare field. The company is mainly engaged in Contract Research Organization (CRO), Contract Development and Manufacturing (CDMO), Contract Sales Organization (CSO), Innovative Pharma Model (IPM) and healthcare business. CMIC support a wide range of pharmaceutical management services such as data management, statistical analysis, medicine consulting, medical writing, audit, and analytical tests, clinical trials for the medical and pharmaceutical industry, human resource services. It is also engaged in providing sales and marketing support for pharmaceuticals.

CMIC HOLDINGS Co (TSE:2309) Headlines

No Headlines